Discover and connect with journalists and influencers around the world, save time on email research, monitor the news, and more.
Recent: |
|
Past: |
|
The FDA is strengthening a warning on the labels of two diabetes drugs to reflect risk of acute kidney injuries. New labels for the two sodium-glucose transport 2 (SGLT-2) drugs -- canagliflozin (Invokana) and dapagliflozin (Farxiga) -- will have more information about acute kidney injuries and add recommendations about how to minimize risk, said the FDA on its website Tuesday. The agency says… → Read More
Large prospective study finds higher risk of gallbladder cancer → Read More
Post-hoc analysis also finds lower risk of hypoglycemia → Read More
T3-T4 therapy improves symptoms, boosts quality of life → Read More
Small cohort with obesity and PCOS saw improvement → Read More
AACE's evidence-based guidelines aims to help physicians → Read More
Concerns about insulin degludec-liraglutide combo didn't trump overall efficacy → Read More
ORLANDO -- For the first time in its 25 year history, the American Association of Clinical Endocrinologists (AACE) will release guidelines for treating obesity. "These are our first comprehensive guidelines for treating obesity," said the president of AACE, George Grunberger, MD, in an interview with MedPage Today. "They've been two years in the making." The guidelines will be released on Friday… → Read More
Controversial changes will reflect amount of added sugars → Read More
But study supports use of MRI as non-invasive liver fat measure → Read More
Metabolic risk appears to start in first months of life, not in womb → Read More
Nwamaka Eneanya, MD, is a nephrologist at Massachusetts General Hospital in Boston with an interest in end-of-life care. Eneanya went to medical school at Meharry Medical College in Tennessee and earned an MPH degree from Harvard T.H. Chan School of Public Health. After graduation, she did her residency at Brigham and Women's Hospital, followed by a nephrology fellowship, also in Boston. She sat… → Read More
* Note that this observational study found that infants born to mothers with gestational diabetes put on more weight in the first 12 weeks of life compared with those born to nondiabetic mothers. * Be aware that birth weights were not significantly different, suggesting postnatal factors as potentially playing a role in these findings. Weeks after birth, infants of mothers with gestational… → Read More
Better access could cut long-term burden on patients → Read More
* Maternal consumption of artificially sweetened beverages (ASBs) during pregnancy was significantly associated with infant body mass index at 1 year of age, according to a longitudinal sudy of healthy pregnant Canadian women. * Note that the mechanism for the association of consumption of ASBs and infant BMI is unclear. Moms who consume artificially sweetened drinks may influence the body mass… → Read More
Researchers ID unique markers in patients with proteinuria and diabetic nephropathy → Read More
Sub-analyses finds those with resistant hypertension see benefits → Read More
Short-term gains in exercise capacity, but no long-term benefits → Read More
Press takes liberty with limited Mediterranean diet study → Read More
In a hypertensive CKD sample, the elderly had fewer events than younger patients → Read More